Clinical Biomarkers for Early Identification of Patients with Intracranial Metastatic Disease

SIMPLE SUMMARY: The development of brain metastases, or intracranial metastatic disease (IMD), is a serious and life-altering complication for many patients with cancer. While there have been substantial advancements in the treatments available for IMD and in our understanding of its pathogenesis, c...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaebe, Karolina, Li, Alyssa Y., Das, Sunit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656478/
https://www.ncbi.nlm.nih.gov/pubmed/34885083
http://dx.doi.org/10.3390/cancers13235973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656478/
https://www.ncbi.nlm.nih.gov/pubmed/34885083
http://dx.doi.org/10.3390/cancers13235973

Ejemplares similares